摘要
随着新药和新疗法的选择,前列腺癌全身治疗的方案正在迅速发展。为了更新共享的泌尿肿瘤实践的背景知识,我们回顾了目前在全身治疗中的陈述和标志。非转移性和转移性疾病的许多新药物正在研究中。同样,正在开发新的目标成像技术,以提高对真正的非转移和真正转移患者的检测率。五种新药已显示对转移性前列腺癌的无进展生存率和总体生存率有效。但是,这些治疗方法的最佳顺序需要进一步研究。新药的耐受性和副作用以及它们对疾病的活性也是至关重要的问题。泌尿肿瘤科团队必须及时了解新的医学疗法,以便有信心与参与前列腺癌决策的其他专业人员进行辩论。在多学科小组讨论中,应分享不同的观点和细微差别,以实现疾病管理中的平衡决策。
关键词: 前列腺癌,雄激素剥夺治疗,抗雄激素,前列腺癌单位,多西他赛,全身治疗。
图形摘要
Current Cancer Drug Targets
Title:Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective
Volume: 21 Issue: 2
关键词: 前列腺癌,雄激素剥夺治疗,抗雄激素,前列腺癌单位,多西他赛,全身治疗。
摘要: The scenario of systemic therapy for prostate cancer is rapidly evolving, with new drugs and new treatment options. To update the background knowledge of shared uro-oncologic practice, we reviewed current statements and landmarks in systemic therapy. A number of new agents are under investigation in non-metastatic and metastatic disease. Similarly, new target imaging technologies are under development to improve the detection rate of true non-metastatic and true metastatic patient. Five new drugs have shown to be effective on progression-free and overall survival in metastatìc prostate cancer. However, the optimal sequencing of these treatments requires further investigation. The tolerability and side effects of the new drugs are also crucial issues to be discussed, as well as their activity against the disease. The uro-oncologic team has to stay updated about new medical therapies in order to be confident in debating with other professionals involved in prostate cancer decision making. Different points of view and nuances should be shared during multidisciplinary group discussions to achieve a balanced decision in disease management.
Export Options
About this article
Cite this article as:
Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective, Current Cancer Drug Targets 2021; 21 (2) . https://dx.doi.org/10.2174/1568009620666201021163919
DOI https://dx.doi.org/10.2174/1568009620666201021163919 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma
Current Pharmaceutical Design The Role of HTS in Drug Discovery at the University of Michigan
Combinatorial Chemistry & High Throughput Screening Editorial
Recent Patents on Anti-Cancer Drug Discovery Extraction, Isolation and Analysis of Chondroitin Sulfate Glycosaminoglycans
Recent Patents on Food, Nutrition & Agriculture Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds The Interplay Between Inflammation and Oxidative Stress in Carcinogenesis
Current Molecular Medicine Patent Selections:
Current Biomarkers (Discontinued) Patent Selections
Recent Patents on Biomarkers Aliphatic Nucleophilic Radiofluorination
Current Radiopharmaceuticals DNA Binding Mode of Transition Metal Complexes, A Relationship to Tumor Cell Toxicity
Current Medicinal Chemistry Imaging Methods in Gene Therapy of Cancer
Current Gene Therapy Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?
Current Topics in Medicinal Chemistry Overview of Protein Kinase B Enzyme: A Potential Target for Breast and Prostate Cancer
Current Molecular Pharmacology Oxidation Inhibits Iron-Induced Blood Coagulation
Current Drug Targets Review on Triggered Liposomal Drug Delivery with a Focus on Ultrasound
Current Cancer Drug Targets Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer
Current Drug Targets Microtubules in Apoptosis Induction: Are They Necessary?
Current Cancer Drug Targets Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets